Hui Jin Selected Research

Ginkgolides

1/2022	Retraction notice to "Ginkgolides B alleviates hypoxia-induced PC-12 cell injury by up-regulation of PLK1" [Biomed. Pharmacother. 115 (2019) 108885].
1/2019	RETRACTED: Ginkgolides B alleviates hypoxia-induced PC-12 cell injury by up-regulation of PLK1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Jin Research Topics

Disease

44	Neoplasms (Cancer) 03/2022 - 02/2006
24	Infections 04/2022 - 05/2008
15	Inflammation (Inflammations) 01/2022 - 10/2015
11	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 10/2006
9	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2008
8	COVID-19 01/2022 - 12/2020
8	Carcinoma (Carcinomatosis) 06/2018 - 07/2013
6	Type 2 Diabetes Mellitus (MODY) 08/2021 - 08/2019
5	Rheumatoid Arthritis 01/2022 - 03/2014
5	Neuroinflammatory Diseases 01/2021 - 01/2020
5	Sepsis (Septicemia) 01/2021 - 01/2019
5	Carcinogenesis 01/2019 - 04/2015
4	Pain (Aches) 01/2022 - 08/2010
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2011
4	Hypoxia (Hypoxemia) 01/2022 - 12/2011
4	Ischemic Stroke 09/2021 - 11/2009
4	Lymphoma (Lymphomas) 03/2021 - 01/2016
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2020 - 01/2019
4	Fibrosis (Cirrhosis) 11/2018 - 08/2009
4	Hepatitis B 01/2016 - 01/2013
4	Mitochondrial Diseases (Mitochondrial Disease) 05/2014 - 02/2010
3	Osteoporosis 12/2022 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 01/2011
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2022 - 04/2015
3	Stroke (Strokes) 12/2021 - 11/2009
3	Human Influenza (Influenza) 04/2021 - 07/2019
3	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2016
3	Enteritis 01/2020 - 11/2018
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 06/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2016
3	Osteoarthritis 01/2018 - 10/2017
3	Heat Stroke (Heatstroke) 01/2018 - 12/2014
3	Burns 06/2017 - 12/2015
3	Diarrhea 01/2012 - 09/2004
2	Asthma (Bronchial Asthma) 02/2022 - 10/2020
2	Myositis (Idiopathic Inflammatory Myopathies) 02/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2021
2	Microscopic Polyangiitis 01/2022 - 10/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2022
2	Paralysis (Palsy) 12/2021 - 09/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 11/2017
2	Thromboembolism 09/2021 - 02/2021
2	Thrombosis (Thrombus) 09/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
13	VaccinesIBA 01/2022 - 06/2013
11	CytokinesIBA 01/2021 - 03/2014
10	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2011
10	AutoantibodiesIBA 03/2022 - 03/2014
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
10	Circular RNAIBA 01/2021 - 01/2018
8	Immunoglobulin G (IgG)IBA 02/2022 - 03/2014
7	Amyloid (Amyloid Fibrils)IBA 01/2021 - 12/2010
6	Pharmaceutical PreparationsIBA 03/2022 - 01/2016
6	Biological ProductsIBA 10/2020 - 06/2013
5	tanshinoneIBA 11/2020 - 03/2012
5	Peptides (Polypeptides)IBA 12/2019 - 12/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 05/2010
4	AntibodiesIBA 01/2022 - 01/2021
4	AntigensIBA 01/2022 - 06/2008
4	CollagenIBA 09/2021 - 08/2009
4	Antiviral Agents (Antivirals)IBA 01/2021 - 08/2011
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2019
4	CateninsIBA 12/2020 - 12/2017
4	Immunoglobulin A (IgA)IBA 12/2020 - 07/2019
4	ChemokinesIBA 10/2020 - 10/2015
4	Amyloid beta-PeptidesIBA 10/2020 - 10/2006
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2018
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 05/2008
3	HLA-DR Antigens (HLA-DR)IBA 02/2022 - 10/2017
3	Neuroprotective AgentsIBA 05/2021 - 10/2006
3	LipidsIBA 01/2021 - 11/2009
3	oxidized low density lipoproteinIBA 01/2021 - 11/2009
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2012
3	p38 Mitogen-Activated Protein KinasesIBA 12/2020 - 03/2011
3	NF-kappa B (NF-kB)IBA 09/2020 - 05/2008
3	Streptozocin (Streptozotocin)FDA Link 02/2020 - 01/2020
3	Poly dA-dT (dT, Poly dA)IBA 01/2020 - 11/2018
3	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2018
3	Phosphotransferases (Kinase)IBA 01/2018 - 01/2011
3	AntioxidantsIBA 12/2016 - 01/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 05/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 05/2010
2	Tyrosine Kinase InhibitorsIBA 03/2022 - 04/2019
2	Histone Deacetylase InhibitorsIBA 01/2022 - 07/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2014
2	GinkgolidesIBA 01/2022 - 01/2019
2	Long Noncoding RNAIBA 12/2021 - 03/2021
2	Guanosine Diphosphate (GDP)IBA 11/2021 - 12/2020
2	Oxygen (Dioxygen)IBA 09/2021 - 12/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2021 - 10/2014
2	Epinephrine (Adrenaline)FDA LinkGeneric 09/2021 - 02/2021
2	LipopolysaccharidesIBA 09/2021 - 11/2020
2	Interleukin-6 (Interleukin 6)IBA 09/2021 - 01/2018

Therapy/Procedure

25	Therapeutics 12/2022 - 02/2009
5	Drug Therapy (Chemotherapy) 01/2020 - 03/2011
4	Punctures 01/2021 - 01/2019
4	Ligation 01/2021 - 01/2019
2	Aftercare (After-Treatment) 01/2022 - 01/2011
2	Immunotherapy 01/2022 - 01/2020